Skip to content

Author

Shuangyin Han

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Transcriptomic analysis identifies FABP5 as a candidate regulator of lipid accumulation in metabolic dysfunction-associated fatty liver disease

Hematic Fabp5 expression and circulating FABP5 concentrations are reduced in experimental and human MAFLD, suggesting that FABP5 is a candidate regulator of hepatic lipid metabolism and warrants further investigation as a potential therapeutic target.

Kai-Shuo Lv, Shu-Hang Zhong, Xiao-Qing Liu et al. · 0 citations
Open access Aug 2026

Gut microbiota-derived metabolites target C5AR1/KDM2A/HCAR3 axis in inflammatory bowel disease: a multi-machine learning algorithms and molecular docking study

This study first constructs a “gut microbiota-metabolite-hub gene” axis in IBD, providing a computational framework for microbiota-targeted precision therapy, and identifying C5AR1/KDM2A/HCAR3 as computationally predicted diagnostic biomarkers and 1,3-Diphenylpropan-2-Ol/3-Indolepropionic Acid as candidate intervention...

Shan-Shan Hu, Lin Fu, Jing Gao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.